CASC2 and ovarian neoplasm: However, downregulation of EIF4A3 reversed the effect of CASC2 reduction when combined with sanguinarine in ovarian tumor cells, while it also reversed the effect of CASC2 on the NF-κB and PI3K/AKT/mTOR pathways.